"Health Canada approves Novartis’ Fabhalta for PNH with haemolytic anaemia" was originally created and published by ...

Indaptus Therapeutics (INDP) announced the Company has received Clinical Trial Authorization from Health Canada to initiate its clinical trial ...

(RTTNews) - Merck (MRK) announced that Health Canada has granted approval for KEYTRUDA, Merck's anti-PD-1 therapy, as a treatment for adult patients with resectable Stage II, IIIA, or IIIB non ...

"Health Canada's approval of iptacopan now provides PNH patients options to assure that they get optimal treatment benefit." The Health Canada approval is based on the Phase III APPLY-PNH trial in ...

company says Ozempic maker Novo Nordisk says it’s the only company in Canada with Health Canada-approved products containing semaglutide. Novo Nordisk told Global News last summer that it had ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...